Applications of whole-genome high-density SNP genotyping

Expert Review of Molecular Diagnostics

Volumn 5, Issue 2, 2005, Pages 159-170

  Craig, David W ^a   Stephan, Dietrich A ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Association study; Comparative genomic hybridization; Linkage study; Loss of heterozygosity; SNP genotyping

Indexed keywords

BIOINFORMATICS; COMPARATIVE GENOMIC HYBRIDIZATION; DATA ANALYSIS; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; GENETIC TRAIT; GENETIC VARIABILITY; GENOME; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE DISEQUILIBRIUM; LOSS OF HETEROZYGOSITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 15444377414     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.2.159     Document Type: Review

References (94)

1. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nature Rev. Genet. 3(4), 299-309 (2002).
2. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nature Genet. 33(4), 518-521 (2003).
3. Kruglyak L, Nickerson DA. Variation is the spice of life. Nature Genet. 27(3), 234-236 (2001).
4. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 296(5576), 2225-2229 (2002). •• One of the first large-scale demonstrations that the human genome can be parsed objectively into haplotype blocks.
5. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12(3), 436-446 (2002).
6. Dearlove AM. High throughput genotyping technologies. Brief Funct. Genomic Proteomic 1(2), 139-150 (2002).
7. Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. Single nucleotide polymorphism seeking long-term association with complex disease. Nucleic Acids Ses. 30(15), 3295-3311 (2002).
8. Chee M, Yang R, Hubbell E et al. Accessing genetic information with high-density DNA arrays. Science 274(5287), 610-614 (1996). •• One of first examples of high-throughput microarray genotyping.
9. Gentalen E, Chee M. A novel method for determining linkage between DNA sequences: hybridization to paired probe arrays. Nucleic Acids Res. 27(6), 1485-1491 (1999).
10. Fan JB, Chen X, Halushka MK et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res. 10(6), 853-860 (2000).
11. Matsuzaki H, Loi H, Dong S et al. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res. 14(3), 414-425 (2004).
12. Liu WM, Di X, Yang G et al. Algorithms for large-scale genotyping microarrays. Bioinformatics 19(18), 2397-2403 (2003).
13. Cutler DJ, Zwick ME, Carrasquillo MM et al. High-throughput variation detection and genotyping using microarrays. Genome Res. 11(11), 1913-1925 (2001).
14. Matsuzaki H et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nature Methods 1(2), 109-111 (2004).
15. Puffenberger EG, Hu-Lince D, Parod JM et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Prof. Natl Acad. Sci. USA 101(32), 11689-11694 (2004). •• Example of using high-density microarray genotyping for identifying a causative mutation.
16. Fan JB, Oliphant A, Shen R et al. Highly parallel SNP genotyping. Cold Spring Harb. Symp. Quant. Biol. 68, 69-78 (2003).
17. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques (Suppl. 56-58), 60-61 (2002).
18. Gunderson KL, Kruglyak S, Graige MS et al. Decoding randomly ordered DNA arrays. Genome Res. 14(5), 870-877 (2004).
19. Murray SS et al. A highly informative SNP linkage panel for human genetic studies. Nature Methods 1(2), 113-117 (2004). • Describes a whole-genome high-density single nucletide polymorphism (SNP) panel focusing on highly informative SNPs.
20. Marnellos G. High-throughput SNP analysis for genetic association studies. Curr. Opin. Drug Discov. Devel. 6(3), 317-321 (2003).
21. Storm N, Darnhofer-Patel B, van den Boom D, Rodi CP. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol. Biol. 212, 241-262 (2003).
22. Jurinke C, van den Boom D, Cantor CR, Koster H. The use of MassARRAY technology for high-throughput genotyping. Adv. Biochem. Eng. Biotechnol. 77, 57-74 (2002).
23. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol. Biol. 170, 103-116 (2001).
24. Bansal A, van den Boom D, Kammerer S et al. Association testing by DNA pooling: an effective initial screen. Proc. Natl Acad. Sci. USA 99(26), 16871-16874 (2002). • Explores the possibility of pooling in association studies.
25. Tang K, Oeth P, Kammerer S et al. Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry. J. Proteome Res. 3(2), 218-227 (2004).
26. Ross P, Hall L, Haff LA. Quantitative approach to single-nucleotide polymorphism analysis using MALDI-TOF mass spectrometry. Biotechniques 29(3), 620-626 (2000).
27. Rosenberg NA, Pritchard JK, Weber JL et al. Genetic structure of human populations. Science 298(5602), 2381-2385 (2002).
28. Matise TC, Sachidanandam R, Clark AG et al. A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am. J. Hum. Genet. 73(2), 271-284 (2003).
29. Shrimpton AE, Levinsohn EM, Yozawitz JM et al. A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 75(1), 92-96 (2004). •• Example of using high-density microarray genotyping for identifying a causative mutation.
30. Schaid DJ, Guenther JC, Christensen GB et al. Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility loci. Am. J. Hum. Genet. 75(6), 948-965 (2004).
31. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nature Genet. 30(1), 97-101 (2002).
32. Evans DM, Cardon LR. Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. Am. J. Hum. Genet. 75(4), 687-692 (2004).
33. John S, Shephard N, Liu G et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75(1), 54-64 (2004).
34. Middleton FA, Pato MT, Gentile KL et al. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-porymorphism (SNP) genotyping assay: a comparison with mictosatellite marker assays and finding of significant linkage to chromosome 6q22. Am. J. Hum. Genet. 74(5), 886-897 (2004).
35. Sellick GS, Longman C, Tolmie J et al. Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res. 32(20), E164 (2004).
36. Sawcer SJ, Maranian M, Singlehurst S et al. Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. Hum. Mol. Genet. 13(17), 1943-1949 (2004). • Comparison between high-density SNP genotyping platforms and microsatellites.
37. Ort J. Analysis of Human Genetic Linkage, 3rd edition. Johns Hopkins University Press, MD, USA (1999).
38. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58(6), 1347-1363 (1996).
39. Lander ES, Green P. Construction of multilocus genetic linkage maps in humans. Proc. Natl Acad. Sci. USA 84(8), 2363-2367 (1987).
40. Elston RC, Stewart J. A general model for the genetic analysis of pedigree data. Hum. Hered. 21(6), 523-542 (1971).
41. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am. J. Hum. Genet. 58(6), 1323-1337 (1996).
42. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20(8), 1233-1240 (2004).
43. Mei R, Galipeau PC, Prass C et al. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res. 10(8), 1126-1137 (2000).
44. Knudson AG Jr. Hereditary cancer, oncogencs, and anti-oncogenes. Cancer Res. 45(4), 1437-1443 (1985).
45. Dumur CI, Dechsukhum C, Ware JL et al. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 81(3), 260-269 (2003).
46. Schubert EL, Hsu L, Cousens LA et al. Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am. J. Pathol. 160(1), 73-79 (2002).
47. Wang ZC, Lin M, Wei LJ et al. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res. 64(1), 64-71 (2004).
48. Zhou X, Mok SC, Chen Z, Li Y, Wong DT. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum. Genet. 115(4), 327-330 (2004).
49. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2(8) RESEARCH0032 (2001).
50. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nature Rev. Genet. 5(2), 89-100 (2004).
51. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429(6990), 446-452 (2004).
52. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet. 33(Suppl.), 228-237 (2003).
53. Whittaker JC, Morris AP. Family-based tests of association and/or linkage. Ann. Hum. Genet. 65(Pt 5), 407-419 (2001).
54. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 273(5281), 1516-1517 (1996).
55. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nature Genet. 26(2), 151-157 (2000).
56. Risch NJ. Searching for genetic determinants in the new millennium. Nature 405(6788), 847-856 (2000).
57. Reich DE, Cargill M, Bolk S et al. Linkage disequilibrium in the human genome. Nature 411(6834), 199-204 (2001).
58. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nature Rev. Genet. 4(8), 587-597 (2003).
59. Cardon LR, Bell JI. Association study designs for complex diseases. Nature Rev. Genet. 2(2), 91-99 (2001).
60. Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nature Genet. 29(2), 233-237 (2001).
61. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nature Rev. Genet. 5(6), 467-475 (2004).
62. Nelson MR, Marnellos G, Kammerer S et al. Large-scale validation of single nucleotide polymorphisms in gene regions. Genome Res. 14(8), 1664-1668 (2004).
63. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genet. 22(2), 139-144 (1999).
64. Fallin D, Cohen A, Essioux L et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res. 11(1), 143-151 (2001).
65. Teng J, Risch N. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. II. Individual genotyping. Genome Res. 9(3), 234-241 (1999).
66. Roses AD. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer's disease. Neurogenetics 1(1), 3-11 (1997).
67. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Ann. Rev. Neurosci. 19, 53-77 (1996).
68. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nature Genet. 32(4), 650-654 (2002).
69. Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 11(12), 2115-2119 (2001).
70. Rosner B. Fundamentals of Biostatistics, fifth edition. Duxbury, Pacific Grove, CA, USA (2000).
71. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125(1-2), 279-284 (2001).
72. Hoh J, Ott J. Mathematical multi-locus approaches to localizing complex human trait genes. Nature Rev. Genet. 4(9), 701-709 (2003).
73. Hoh J, Wille A, Zee R et al. Selecting SNPs in two-stage analysis of disease association data: a model-free approach. Ann. Hum. Genet. 64(Pt 5), 413-417 (2000).
74. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nature Genet. 36(5), 512-517 (2004).
75. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75(3), 353-362 (2004).
76. Pritchard JK, Donnelly P. Case-control studies of association in structured or admixed populations. Theor. Popul. Biol. 60(3), 227-237 (2001).
77. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155(2), 945-959 (2000).
78. Hao K, Li C, Rosenow C, Wong WH. Detect and adjust for population stratification in population-based association study using genomic control markers: an application of Affymetrix Genechip® Human Mapping 10K array. Eur. J. Hum. Genet. 12(12), 1001-1006 (2004).
79. Wright A, Charlesworth B, Rudan I, Carothers A, Campbell H. A polygenic basis for late-onset disease. Trends Genet. 19(2), 97-106 (2003).
80. Schulze TG, McMahon FJ. Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am. J. Med. Genet. 114(1), 1-11 (2002).
81. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52(3), 506-516 (1993).
82. Sun F, Flanders WD, Yang Q, Khoury MJ. Transmission disequilibrium test (TDT) when only one parent is available: the 1-TDT. Am. J. Epidemiol. 150(1), 97-104 (1999).
83. Le Hellard S, Ballereau SJ, Visscher PM et al. SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysis. Nucleic Acids Res. 30(15), E74 (2002).
84. Buetow KH, Edmonson M, MacDonald R et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl Acad. Sci. USA 98(2), 581-584 (2001).
85. Kammerer S, Burns-Hamuro LL, Ma Y et al. Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc. Natl Acad. Sci. USA 100(7), 4066-4071 (2003).
86. Butcher LM, Meaburn E, Dale PS et al. Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol. Psychiatry 28 (2004).
87. Butcher LM, Meaburn E, Liu L et al. Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav. Genet. 34(5), 549-555 (2004).
88. Sherry ST, Ward MH, Kholodov M et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29(1), 308-311 (2001).
89. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 291(5507), 1304-1351 (2001).
90. Cai Z, Tsung EF, Marinescu VD, Ramoni MF, Riva A, Kohane IS. Bayesian approach to discovering pathogenic SNPs in conserved protein domains. Hum. Mutat. 24(2), 178-184 (2004).
91. Thompson D, Easton DF, Goldgar DE. A full-likelihood method for the evaluation of causality of sequence variants from family data. Am. J. Hum. Genet. 73(3), 652-655 (2003).
92. Grantham R. Amino acid difference formula to help explain protein evolution. Science 185(4154), 862-864 (1974).
93. Stenson PD, Ball EV, Mort M et al. Human Gene Mutation Database (HGMD), 2003 update. Hum. Mutat. 21(6), 577-581 (2003).
94. Warrington JA, Shah NA, Chen X et al. New developments in high-throughput resequencing and variation detection using high density microarrays. Hum. Mutat. 19(4), 402-409 (2002).